A CLINICAL STUDY OF ERYTHROMYCIN STEARATE AND ERYTHROMYCIN ETHYL SUCCINATE IN OFFICE PRACTICE.
D002177:Candidiasis; D004351:Drug Resistance; D004352:Drug Resistance, Microbial; D004358:Drug Therapy; D004917:Erythromycin / Q000031:analogs & derivatives; D004927:Escherichia coli Infections; D006801:Humans; D007251:Influenza, Human; D009343:Neisseria; D012141:Respiratory Tract Infections; D013203:Staphylococcal Infections; D013296:Streptococcus pneumoniae; D013386:Succinates; D014116:Toxicology
D013386:Succinates; D004917:Erythromycin; C011462:erythromycin stearate
DIPLOCOCCUS PNEUMONIAE; DRUG RESISTANCE, MICROBIAL; DRUG THERAPY; ERYTHROMYCIN; ESCHERICHIA COLI INFECTIONS; INFLUENZA; MONILIASIS; NEISSERIA; RESPIRATORY TRACT INFECTIONS; STAPHYLOCOCCAL INFECTIONS; TOXICOLOGIC REPORT